KRAS and cancer: Mice similarly exhibit a bias of specific oncogenic Kras mutations towards different cancer types as different mutant Kras alleles have different tumorigenic potential when activated in different tissues (Li et al., 2018; Poulin et al., 2019; Winters et al., 2017; Wong et al., 2020; Zafra et al., 2020).